Article Details

Active Biotech: Tasquinimod clinical development in multiple myeloma advances into ...

Retrieved on: 2021-10-03 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

Active Biotech: Tasquinimod clinical development in multiple myeloma advances into .... View article details on hiswai:

Excerpt

... and anti-CD38 monoclonal antibodies. While none of the patients formally achieved a partial response, two patients with progressive myeloma at study ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up